Literature DB >> 22843259

MRI characteristics and scoring in HDLS due to CSF1R gene mutations.

Christina Sundal1, Jay A Van Gerpen, Alexandra M Nicholson, Christian Wider, Elizabeth A Shuster, Jan Aasly, Salvatore Spina, Bernardino Ghetti, Sigrun Roeber, James Garbern, Anne Borjesson-Hanson, Alex Tselis, Russell H Swerdlow, Bradley B Miller, Shinsuke Fujioka, Michael G Heckman, Ryan J Uitti, Keith A Josephs, Matt Baker, Oluf Andersen, Rosa Rademakers, Dennis W Dickson, Daniel Broderick, Zbigniew K Wszolek.   

Abstract

OBJECTIVE: To describe the brain MRI characteristics of hereditary diffuse leukoencephalopathy with spheroids (HDLS) with known mutations in the colony-stimulating factor 1 receptor gene (CSF1R) on chromosome 5.
METHODS: We reviewed 20 brain MRI scans of 15 patients with autopsy- or biopsy-verified HDLS and CSF1R mutations. We assessed sagittal T1-, axial T1-, T2-, proton density-weighted and axial fluid-attenuated inversion recovery images for distribution of white matter lesions (WMLs), gray matter involvement, and atrophy. We calculated a severity score based on a point system (0-57) for each MRI scan.
RESULTS: Of the patients, 93% (14 of 15) demonstrated localized WMLs with deep and subcortical involvement, whereas one patient revealed generalized WMLs. All WMLs were bilateral but asymmetric and predominantly frontal. Fourteen patients had a rapidly progressive clinical course with an initial MRI mean total severity score of 16.7 points (range 10-33.5). Gray matter pathology and brainstem atrophy were absent, and the corticospinal tracts were involved late in the disease course. There was no enhancement, and there was minimal cerebellar pathology.
CONCLUSION: Recognition of the typical MRI patterns of HDLS and the use of an MRI severity score might help during the diagnostic evaluation to characterize the natural history and to monitor potential future treatments. Indicators of rapid disease progression were symptomatic disease onset before 45 years, female sex, WMLs extending beyond the frontal regions, a MRI severity score greater than 15 points, and mutation type of deletion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843259      PMCID: PMC3413763          DOI: 10.1212/WNL.0b013e318263575a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.

Authors:  Arnaud Charil; Alain Dagher; Jason P Lerch; Alex P Zijdenbos; Keith J Worsley; Alan C Evans
Journal:  Neuroimage       Date:  2006-11-16       Impact factor: 6.556

2.  MRI of Susac's syndrome.

Authors:  Rocky Saenz; Albert W Quan; Alvaro Magalhaes; Karl Kish
Journal:  AJR Am J Roentgenol       Date:  2005-05       Impact factor: 3.959

3.  Autosomal dominant leukodystrophy with axonal spheroids and pigmented glia: clinical and neuropathological characteristics.

Authors:  Kyoko Itoh; Kensuke Shiga; Kentaro Shimizu; Manabu Muranishi; Masanori Nakagawa; Shinji Fushiki
Journal:  Acta Neuropathol       Date:  2005-11-23       Impact factor: 17.088

4.  Two cases of LENAS: diagnosis by MRI and biopsy.

Authors:  B Mayer; C Oelschlaeger; K Keyvani; T Niederstadt
Journal:  J Neurol       Date:  2007-08-21       Impact factor: 4.849

Review 5.  Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method.

Authors:  D J Loes; C Peters; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1999-02       Impact factor: 3.825

6.  Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS.

Authors:  B M Keegan; C Giannini; J E Parisi; C F Lucchinetti; B F Boeve; K A Josephs
Journal:  Neurology       Date:  2008-02-20       Impact factor: 9.910

7.  Subcallosal striations: early findings of multiple sclerosis on sagittal, thin-section, fast FLAIR MR images.

Authors:  S Palmer; W G Bradley; D Y Chen; S Patel
Journal:  Radiology       Date:  1999-01       Impact factor: 11.105

Review 8.  Grey matter pathology in multiple sclerosis.

Authors:  Jeroen J G Geurts; Frederik Barkhof
Journal:  Lancet Neurol       Date:  2008-09       Impact factor: 44.182

9.  Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred.

Authors:  Yasuhiko Baba; Bernardino Ghetti; Matthew C Baker; Ryan J Uitti; Michael L Hutton; Keiji Yamaguchi; Thomas Bird; Wenlang Lin; Michael W DeLucia; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Acta Neuropathol       Date:  2006-03-08       Impact factor: 17.088

10.  White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study.

Authors:  C Ryberg; E Rostrup; K Sjöstrand; O B Paulson; F Barkhof; P Scheltens; E C W van Straaten; F Fazekas; R Schmidt; T Erkinjuntti; L-O Wahlund; A M Basile; L Pantoni; D Inzitari; G Waldemar
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-12       Impact factor: 3.825

View more
  37 in total

1.  Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.

Authors:  T Konno; D F Broderick; N Mezaki; A Isami; D Kaneda; Y Tashiro; T Tokutake; B M Keegan; B K Woodruff; T Miura; H Nozaki; M Nishizawa; O Onodera; Z K Wszolek; T Ikeuchi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-15       Impact factor: 3.825

2.  Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.

Authors:  Christina Sundal; Matt Baker; Rosa Rademakers; Oluf Andersen; Virginija Karrenbauer; Marte Gustavsen; Sahl Bedri; Anna Glaser; Kjell-Morten Myhr; Kristoffer Haugarvoll; Henrik Zetterberg; Hanne Harbo; Ingrid Kockum; Jan Hillert; Zbigniew Wszolek
Journal:  Eur J Neurol       Date:  2014-10-13       Impact factor: 6.089

Review 3.  Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System.

Authors:  Violeta Chitu; Şölen Gokhan; Sayan Nandi; Mark F Mehler; E Richard Stanley
Journal:  Trends Neurosci       Date:  2016-04-12       Impact factor: 13.837

Review 4.  CSF1R-related leukoencephalopathy: A major player in primary microgliopathies.

Authors:  Takuya Konno; Koji Kasanuki; Takeshi Ikeuchi; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Neurology       Date:  2018-11-14       Impact factor: 9.910

5.  Intrafamilial heterogeneity in hereditary diffuse leukoencephalopathy with axonal spheroids.

Authors:  Carolina Lopes; Sara Duarte; Ernestina Santos; Carina Reis; Madalena Pinto
Journal:  Neurol Clin Pract       Date:  2019-12

6.  Altered structural and functional connectivity in CSF1R-related leukoencephalopathy.

Authors:  Fei-Xia Zhan; Ze-Yu Zhu; Qing Liu; Hai-Yan Zhou; Xing-Hua Luan; Xiao-Jun Huang; Xiao-Li Liu; Wo-Tu Tian; Shi-Ge Wang; Xiao-Xuan Song; Guang Chen; Ming-Liang Zhao; Ying Wang; Hui-Dong Tang; Jiong Hu; Sheng-Di Chen; Bin-Yin Li; Li Cao
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

7.  Imaging features in conventional MRI, spectroscopy and diffusion weighted images of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS).

Authors:  Benjamin Bender; Uwe Klose; Tobias Lindig; Saskia Biskup; Thomas Nägele; Ludger Schöls; Kathrin N Karle
Journal:  J Neurol       Date:  2014-09-20       Impact factor: 4.849

8.  Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).

Authors:  Violeta Chitu; Solen Gokhan; Maria Gulinello; Craig A Branch; Madhuvati Patil; Ranu Basu; Corrina Stoddart; Mark F Mehler; E Richard Stanley
Journal:  Neurobiol Dis       Date:  2014-12-09       Impact factor: 5.996

9.  Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts.

Authors:  Mark Bang-Wei Tan; Louis Elliott McAdory
Journal:  J Radiol Case Rep       Date:  2016-03-31

10.  Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids.

Authors:  Yaqing Shu; Ling Long; Siyuan Liao; Jiezheng Yang; Jianfang Li; Wei Qiu; Yu Yang; Jian Bao; Aiming Wu; Xueqiang Hu; Zhengqi Lu
Journal:  BMC Neurol       Date:  2016-09-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.